CHG Dressings in Children With Central Lines
What is the purpose of this trial?
The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the number of unscheduled central catheter dressing changes compared to standard clear Tegaderm IV dressing in pediatric patients between the ages of 2 months to 18 years with central venous access. Secondarily, we will monitor contact skin irritation and central line associated blood stream infections.
- 2 Months - 18 Years
- Yale University School of Medicine
- Last Updated:
- Study HIC#: